Carrier‐Free Self‐Assembly Nano‐Sonosensitizers for Sonodynamic‐Amplified Cuproptosis‐Ferroptosis in Glioblastoma Therapy
Advanced Science · 2024-06 · 11 (23)
DOI: 10.1002/advs.202402516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.04.2024. Verfasst von Yang Zhu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350209, China. Hauptthemen laut MEDLINE: Ferroptosis, Glioblastoma, Copper, Chlorophyllides. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Medical University, Joint Funds for the innovation of science and Technology, Technology Platform Construction Project of Fujian Province.
Abstract (Originalsprache)
Cuproptosis is a newly discovered form of programmed cell death significantly depending on the transport efficacy of copper (Cu) ionophores. However, existing Cu ionophores, primarily small molecules with a short blood half‐life, face challenges in transporting enough amounts of Cu ions into tumor cells. This work describes the construction of carrier‐free nanoparticles (Ce6@Cu NPs), which self‐assembled by the coordination of Cu 2+ with the sonosensitizer chlorin e6 (Ce6), facilitating sonodynamic‐triggered combination of cuproptosis and ferroptosis. Ce6@Cu NPs internalized by U87MG cells induce a sonodynamic effect and glutathione (GSH) depletion capability, promoting lipid peroxidation and eventually inducing ferroptosis. Furthermore, Cu + concentration in tumor cells significantly increases as Cu 2+ reacts with reductive GSH, resulting in the downregulation of ferredoxin‐1 and lipoyl synthase. This induces the oligomerization of lipoylated dihydrolipoamide S‐acetyltransferase, causing proteotoxic stress and irreversible cuproptosis. Ce6@Cu NPs possess a satisfactory ability to penetrate the blood‐brain barrier, resulting in significant accumulation in orthotopic U87MG‐Luc glioblastoma. The sonodynamic‐triggered combination of ferroptosis and cuproptosis in the tumor by Ce6@Cu NPs is evidenced both in vitro and in vivo with minimal side effects. This work represents a promising tumor therapeutic strategy combining ferroptosis and cuproptosis, potentially inspiring further research in developing logical and effective cancer therapies based on cuproptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350209, China.
- Fujian Provincial Institutes of Brain Disorders and Brain Sciences, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350209, China.
- Department of Neurosurgery, National Regional Medical Center, The First Affiliated Hospital, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350212, China.
- Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
ORCID-Profile: Xiaoyuan Chen
Förderung
- Fujian Medical University
- Joint Funds for the innovation of science and Technology
- Technology Platform Construction Project of Fujian Province
- National University of Singapore
- National Medical Research Council
- Singapore Ministry of Education
- National Research Foundation
- Ethical Committee of Fujian Medical University
Zitieren
APA
Zhu, Y., Niu, X., Ding, C., Lin, Y., Fang, W., Yan, L., Cheng, J., Zou, J., Tian, Y., Huang, W., Huang, W., Pan, Y., Wu, T., Chen, X., & Kang, D. (2024). Carrier‐Free Self‐Assembly Nano‐Sonosensitizers for Sonodynamic‐Amplified Cuproptosis‐Ferroptosis in Glioblastoma Therapy. Advanced Science, 11(23). https://doi.org/10.1002/advs.202402516
Vancouver
Zhu Y, Niu X, Ding C, Lin Y, Fang W, Yan L, et al. Carrier‐Free Self‐Assembly Nano‐Sonosensitizers for Sonodynamic‐Amplified Cuproptosis‐Ferroptosis in Glioblastoma Therapy. Advanced Science. 2024;11(23). doi:10.1002/advs.202402516
BibTeX
@article{Zhu2024,
author = {Zhu, Yang and Niu, Xuegang and Ding, Chengyu and Lin, Yuanxiang and Fang, Wenhua and Yan, Lingjun and Cheng, Junjie and Zou, Jianhua and Tian, Yu and Huang, Wei and Huang, Wen and Pan, Yuanbo and Wu, Tiantian and Chen, Xiaoyuan and Kang, Dezhi},
title = {Carrier‐Free Self‐Assembly Nano‐Sonosensitizers for Sonodynamic‐Amplified Cuproptosis‐Ferroptosis in Glioblastoma Therapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {23},
doi = {10.1002/advs.202402516}
}
EUVIMED